Tom Luedde

39.6k total citations · 13 hit papers
377 papers, 18.5k citations indexed

About

Tom Luedde is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Tom Luedde has authored 377 papers receiving a total of 18.5k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Epidemiology, 104 papers in Hepatology and 99 papers in Surgery. Recurrent topics in Tom Luedde's work include Liver Disease Diagnosis and Treatment (80 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (41 papers) and Liver physiology and pathology (40 papers). Tom Luedde is often cited by papers focused on Liver Disease Diagnosis and Treatment (80 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (41 papers) and Liver physiology and pathology (40 papers). Tom Luedde collaborates with scholars based in Germany, United States and Netherlands. Tom Luedde's co-authors include Christian Trautwein, Robert F. Schwabe, Frank Tacke, Christoph Roderburg, Mihael Vucur, Nikolaus Gaßler, Henning W. Zimmermann, Christoph Roderburg, Neil Kaplowitz and Manolis Pasparakis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Tom Luedde

351 papers receiving 18.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma

2011 1.1k citations Tom Luedde et al. profile →
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer

2019 798 citations Jakob Nikolas Kather, Niels Halama et al. profile →
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis

2010 669 citations Christoph Roderburg, Mihael Vucur et al. profile →
Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis #

2009 627 citations Ralf Weiskirchen, Henning W. Zimmermann et al. profile →
Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study

2019 611 citations Jakob Nikolas Kather, Johannes Krisam et al. PLoS Medicine profile →
Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance

2014 573 citations Tom Luedde et al. profile →
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation

2013 516 citations Tom Luedde, Mathias Heikenwälder et al. profile →
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury

2011 495 citations Mihael Vucur, Tom Luedde et al. profile →
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis

2017 421 citations Tom Luedde, Claus Hellerbrand et al. profile →
Apoptosis and necroptosis in the liver: a matter of life and death

2018 420 citations Tom Luedde et al. profile →
Deep learning in cancer pathology: a new generation of clinical biomarkers

2020 362 citations Tom Luedde, Jakob Nikolas Kather et al. profile →
Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury

2016 262 citations Tom Luedde, Christian Trautwein et al. profile →
Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma

2022 155 citations Tom Luedde et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tom Luedde Germany	65	6.6k	5.4k	5.0k	3.6k	3.3k	377	18.5k
Christian Trautwein Germany	102	15.3k 2.3×	9.7k 1.8×	12.9k 2.6×	6.9k 1.9×	4.5k 1.3×	709	36.2k
Valérie Paradis France	78	13.3k 2.0×	4.5k 0.8×	12.0k 2.4×	1.2k 0.3×	2.3k 0.7×	435	25.1k
Frank Tacke Germany	104	22.5k 3.4×	9.2k 1.7×	16.5k 3.3×	11.4k 3.2×	3.5k 1.1×	708	45.5k
Shusen Zheng China	66	4.2k 0.6×	10.2k 1.9×	4.1k 0.8×	2.3k 0.6×	5.5k 1.7×	914	22.1k
Ming‐Shiang Wu Taiwan	70	3.2k 0.5×	4.0k 0.7×	1.7k 0.3×	2.0k 0.6×	1.7k 0.5×	596	20.0k
Marc Ferrante Belgium	64	8.9k 1.3×	4.6k 0.8×	866 0.2×	4.7k 1.3×	797 0.2×	543	21.4k
M. Kay Washington United States	78	2.8k 0.4×	8.4k 1.5×	1.9k 0.4×	2.6k 0.7×	3.3k 1.0×	360	21.1k
Norio Hayashi Japan	81	7.9k 1.2×	11.6k 2.1×	7.9k 1.6×	4.8k 1.3×	1.8k 0.5×	623	26.4k
Wei Wang China	54	2.0k 0.3×	2.9k 0.5×	2.1k 0.4×	426 0.1×	1.7k 0.5×	657	12.2k
Anthony J. Demetris United States	81	5.3k 0.8×	3.4k 0.6×	8.4k 1.7×	3.7k 1.0×	1.3k 0.4×	379	23.3k

Countries citing papers authored by Tom Luedde

Since Specialization

Citations

This map shows the geographic impact of Tom Luedde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Luedde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Luedde more than expected).

Fields of papers citing papers by Tom Luedde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Luedde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Luedde. The network helps show where Tom Luedde may publish in the future.

Co-authorship network of co-authors of Tom Luedde

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Luedde. A scholar is included among the top collaborators of Tom Luedde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Luedde. Tom Luedde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

David, Steven, Lena Häberle, Tom Luedde, et al.. (2025). Most oncological pancreas resections must consider the mesopancreas. BMC Cancer. 25(1). 200–200.

Schneider, Kai Markus, Feng Cao, Helen Huang, et al.. (2025). The Lipidomic Profile Discriminates Between MASLD and MetALD. Alimentary Pharmacology & Therapeutics. 61(8). 1357–1371. 2 indexed citations

Holtfreter, Martha, Johannes Mischlinger, Bernhard Hemmerlein, et al.. (2025). A rare case of lingual mucosal leishmaniasis caused by reactivation of Leishmania infantum infection. BMC Infectious Diseases. 25(1). 234–234. 1 indexed citations

Koppe, Christiane, Diran Herebıan, Anne T. Schneider, et al.. (2025). The ferroptosis mediator ACSL4 fails to prevent disease progression in mouse models of MASLD. Hepatology Communications. 9(6).

Loosen, Sven H., Markus S. Jördens, Catherine Leyh, et al.. (2024). Long-Term Intake of Proton-Pump Inhibitors Could Be Associated with an Increased Incidence of Liver Cancer in Women. Cancers. 16(8). 1517–1517.

Wang, Guan‐Wu, Jens T. Siveke, Sven Arke Lang, et al.. (2024). Body Composition in Cholangiocarcinoma Affects Immune Cell Populations in the Tumor and Normal Liver Parenchyma. Journal of Clinical and Experimental Hepatology. 15(2). 102460–102460. 1 indexed citations

Creasy, Kate Townsend, Jan Clusmann, Alexander Koch, et al.. (2024). Machine learning uncovers manganese as a key nutrient associated with reduced risk of steatotic liver disease. Liver International. 44(10). 2807–2821. 7 indexed citations

Demir, Münevver, Alexander Wree, Tom Luedde, et al.. (2023). Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from a German real‐world cohort. Alimentary Pharmacology & Therapeutics. 57(11). 1313–1325. 35 indexed citations

Loosen, Sven H., et al.. (2023). A New Nomogram-Based Prediction Model for Postoperative Outcome after Sigmoid Resection for Diverticular Disease. Medicina. 59(6). 1083–1083. 4 indexed citations

10.

Möllenhoff, Kathrin, Frederik L. Giesel, Gerald Antoch, et al.. (2023). Selective Internal Radiotherapy in Germany: a review of indications and hospital mortality from 2012 to 2019. Journal of Clinical and Translational Research. 9(2). 123–132. 4 indexed citations

11.

Berres, Marie‐Luise, Maria A. González-Carmona, Dominik Paul Modest, et al.. (2023). Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC). BMC Cancer. 23(1). 470–470. 2 indexed citations

12.

Schira‐Heinen, Jessica, Rossella Pellegrino, Lara R. Heij, et al.. (2023). Uncovering Novel Roles of miR-122 in the Pathophysiology of the Liver: Potential Interaction with NRF1 and E2F4 Signaling. Cancers. 15(16). 4129–4129. 1 indexed citations

13.

Mohareer, Krishnaveni, U. Deva Priyakumar, Tom Luedde, et al.. (2022). Staufen‐2 functions as a cofactor for enhanced Rev‐mediated nucleocytoplasmic trafficking of HIV ‐1 genomic RNA via the CRM1 pathway. FEBS Journal. 289(21). 6731–6751. 3 indexed citations

14.

Jördens, Markus S., et al.. (2021). Prevalence of Lung Metastases among 19,321 Metastatic Colorectal Cancer Patients in Eight Countries of Europe and Asia. Current Oncology. 28(6). 5035–5040. 8 indexed citations

15.

Mohr, Raphael, Burcin Özdirik, Joeri Lambrecht, et al.. (2021). From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis. International Journal of Molecular Sciences. 22(3). 1492–1492. 21 indexed citations

16.

Kather, Jakob Nikolas, Johannes Krisam, Pornpimol Charoentong, et al.. (2019). Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study. PLoS Medicine. 16(1). e1002730–e1002730. 611 indexed citations breakdown →

17.

Friemel, Juliane, Lukas Frick, Kristian Unger, et al.. (2019). Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach. Molecular Cancer Research. 17(7). 1493–1502. 22 indexed citations

18.

Kather, Jakob Nikolas, Pornpimol Charoentong, Meggy Suarez‐Carmona, et al.. (2018). High-Throughput Screening of Combinatorial Immunotherapies with Patient-Specific In Silico Models of Metastatic Colorectal Cancer. Cancer Research. 78(17). 5155–5163. 33 indexed citations

19.

Roderburg, Christoph, Mark Luedde, David Vargas Cardenas, et al.. (2012). miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. Journal of Hepatology. 58(4). 736–742. 104 indexed citations

20.

Wunderlich, F. Thomas, Tom Luedde, Stephan Singer, et al.. (2008). Hepatic NF-κB essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis. Proceedings of the National Academy of Sciences. 105(4). 1297–1302. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact